Skip to content

Mobile phone in oral cancer detection in rural settings

Mobile oral cancer screening system for low-resource settings - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057181
Enrollment
350
Registered
2023-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue Health Condition 2: K135- Oral submucous fibrosis

Interventions

None listed

Sponsors

National Institutes of Health, United States
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ALl individuals above 18 years and having Clinically suspicious oral lesions which are indicated for biopsy.

Exclusion criteria

Exclusion criteria: 1. Individuals less than 18 years 2. Pregnant women 3. Individuals currently undergoing treatment for malignancy 4. Individuals having acute illness or undergoing treatment for tuberculosis

Design outcomes

Primary

MeasureTime frame
The proposed dual mode intraoral imaging system will deliver new & imperatively needed capabilities to the end users in low resource setting. This artificial intelligence integrated system will: (1) detect suspicious regions with high sensitivity & specificity; (2) enable automatic, accurate, & objective in situ diagnosis; & in screening program settings or nodal center settings, the device will triage suspicious or non-suspicious lesions. Timepoint: 1. Optimize a mobile imaging system for low-resource setting in year 1 2. Develop mobile based deep learning image classification in year 1 3. Validate the clinical usefulness of the mobile imaging system in year 2

Secondary

MeasureTime frame
Final outcome of the study is to achieve Diagnostic sensitivity & specificity of: 1) 95 % for distinguishing OSCC from healthy sites; (2) 90% for distinguishing OPML from healthy tissues; and (3) 85% for distinguishing non-neoplastic lesion from healthy, oral cancer, or OPML tissues.Timepoint: The diagnostic accuracy, sensitivity & specificity will be achieved at the end of second year

Countries

India

Contacts

Public ContactDr Amritha Suresh

KLE Societys Institute of Dental Sciences

praveen.birur@gmail.com09845136960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026